Limelight Networks Enhances DDoS Security Services with Faster Mitigation of Malicious Website Attacks
Limelight Networks, Inc. (Nasdaq: LLNW), a global leader in digital content delivery, today introduced new capabilities to its DDoS Attack Interceptor Service that provide high-capacity on-network scrubbing and a scalable range of protection measures for web infrastructure, with the ability to easily increase protection as security requirements change.
Protecting websites from online attacks and cyber threats is one of the most pressing security challenges today. For example, data from Limelight’s State of Cybersecurity Report: SE Asia shows consumers are very concerned about the security of ecommerce sites, with 72 percent saying they have a negative opinion of a brand after hearing that it has suffered a cyberattack. In addition, 51 percent of online websites feel they are vulnerable to attacks that could have significant financial and brand implications, despite having protections already in place.
Limelight DDoS Attack Interceptor (DAI) is a comprehensive, multi-layer solution that offers protection from even the largest and most complex DDoS attacks before they can impact website performance. DAI provides layers of defense, including detection of malicious traffic and proactive notification. The new capabilities add high-capacity on-network scrubbing for fast mitigation even while under attack.
By integrating DDoS mitigation capabilities directly into Limelight’s massive global private network infrastructure, attack traffic can be scrubbed in multiple regional locations at high capacity without needing to be diverted to a separate network and returned to the Content Delivery Network (CDN) for delivery. Limelight provides superior delivery performance, even under the largest DDoS attacks.
Limelight offers multiple DDoS attack detection and prevention options, making it easy for customers to choose the appropriate level of protection. In addition to a standard DAI offering, Limelight is now providing two additional DDoS protection levels:
- An entry-level offering with integrated monitoring and per-mitigation pricing is available for organizations that need to monitor the frequency of DDoS attacks and be prepared to respond when necessary
- A premium offering with unlimited mitigations is available for organizations that want the assurance of mitigating multiple DDoS attacks for a fixed price
All levels include multiple detection locations at the edge of the CDN for faster detection, and attack mitigation by a dedicated 24/7 security operations center.
To make it easy for organizations that are not currently protected by a DDoS solution to monitor the frequency of attacks and quickly respond when necessary, customers who sign up for Limelight’s per-incident DDoS mitigation protection will receive their first DDoS mitigation free of charge for a limited time.
“Today, almost every type of online service is at risk for cyber-attacks. At best, a DDoS attack will cause inconvenience -- at worst it can bring down an entire business,” said Steve Miller-Jones, Senior Director of Product Management at Limelight Networks. “DDoS Attack Interceptor offers a range of options and price points to help online organizations guard their web presence. With the addition of our new capabilities, Limelight’s DDoS mitigation capability is more scalable and faster than ever.”
For more information on DDoS Attack Interceptor, see https://www.limelight.com/security.
About Limelight
Limelight Networks, a global leader in
digital content delivery, empowers customers to better engage online
audiences by enabling them to securely manage and globally deliver
digital content, on any device. The company’s Limelight Orchestrate
Platform includes a global infrastructure with a fully-integrated suite
of capabilities and services to help you address all your content
delivery needs. The Orchestrate Platform solves your most important
content delivery challenges so you can deliver the next great digital
experience anywhere. For more information, please visit www.limelight.com
and follow us on Twitter,
Facebook
and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171213006008/en/
Contact information
Press Contact:
SHIFT Communications
Lori Niquette,
617-779-1800
Limelight@shiftcomm.com
or
Investor
Inquiries:
ir@limelight.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 18:46:00 EEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 18:44:00 EEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 18:00:00 EEST | Press release
LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances automated testing workflows by enabling the generation of new test cases using real execution data. Developers can leverage
The Six Winning Projects of the 12 th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 17:58:00 EEST | Press release
Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the 12th edition of the IBSA Foundation Fellowship The € 32,000 fellowships were awarded to research projects in five scientific areas: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology and healthy aging/regenerative medicine. In particular, this latter category has attracted growing interes
Rigaku Completes New Building at Yamanashi Plant27.5.2025 17:00:00 EEST | Press release
Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two key objectives in mind. One objective is to further reinforce the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom